Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
about
Do female cancer patients display better survival rates compared with males? Analysis of the Korean National Registry data, 2005-2009Gender differences in survival and the use of primary care prior to diagnosis of three cancers: an analysis of routinely collected UK general practice data.Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study.A multicenter phase II study of belotecan, a new camptothecin analogue, in elderly patients with previously untreated, extensive-stage small cell lung cancer.Do HIV-infected non-small cell lung cancer patients receive guidance-concordant care?Treatment of advanced non small cell lung cancer in routine care: a retrospective analysis of 212 consecutive patients treated in a community based oncology group practiceDetermining chemotherapy tolerance in older patients with cancer.Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes.A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer.Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study.Challenges in Implementing Personalized Medicine for Lung Cancer within a National Healthcare SystemComparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509.Comorbidity is independently associated with poor outcome in extremity soft tissue sarcoma.Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine.Customizing systemic therapy in patients with advanced non-small cell lung cancer.Sex disparities in cancer mortality and survival.Impact of comorbidity on lung cancer mortality - a report from the Liverpool Lung Project.Management of elderly patients.How do patient and hospital features influence outcomes in small-cell lung cancer in England?Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapiesComorbid chronic diseases and their associations with quality of life among gynecological cancer survivorsComorbidity in elderly cancer patients in relation to overall and cancer-specific mortality.Chemotherapy Treatment of Elderly Patients (≥70 Years) with Non-Small Cell Lung Cancer: A Seven-Year Retrospective Study of Real-Life Clinical Practice at Karolinska University Hospital, SwedenIntensive care admission of cancer patients: a comparative analysisSocial differences in lung cancer management and survival in South East England: a cohort study.Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans.LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspectiveSquamous cell carcinoma of the lung with simultaneous metastases to peritoneum and skeletal muscle.Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger Counterparts.Chemotherapy for patients with advanced lung cancer receiving long-term oxygen therapy.A critical exploration of the International Classification of Functioning, Disability, and Health (ICF) framework from the perspective of oncology: recommendations for revisionPrediction of mortality after radical prostatectomy by Charlson comorbidity index.Renal Function and All-Cause Mortality Risk Among Cancer PatientsNon-small cell lung cancer in the elderly: defining treatment options.Comorbidity and survival of Danish lung cancer patients from 2000-2011: a population-based cohort study.The impact of comorbidity on cancer survival: a reviewImpact of age on adjuvant chemotherapy after radical resection in patients with non-small cell lung cancerIs surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy?Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients.Are TKIs favourable for the elderly with non-small-cell lung cancer?
P2860
Q30585188-EA4916DC-3913-4677-AC12-1F79F8DEB995Q30836096-FAEA3EBD-1078-46A3-ACC5-A94AB7794909Q33404434-DF0DA450-DBBB-45B1-838D-4AB7B8B21DBDQ33409548-A77A0F51-CB20-4205-9B91-8B75E59B7713Q33719504-046B6659-C06C-492B-88E5-39197079167FQ33860259-D46D46E4-C297-4958-81FB-5CB0E41664CAQ34155010-34972F2F-21F9-4FB5-883A-EF09A9F0A511Q34266302-C6856883-CCFB-4FE6-885C-DB9F27965DF4Q34433040-15901040-10C8-4D7C-815A-687AED30174BQ34505182-C6B218CA-5B6E-4C44-852F-2AD8D0AA7F6FQ34608597-43CFC63E-AAB4-487A-B52D-058BD1F5EA93Q34786733-24C6F676-0E9D-4F6D-BD13-6B1FA7013E16Q35086579-F820F791-35EB-4A05-85C5-35C3A1FEAE62Q35097723-6A567F70-4EA9-4604-BEBA-C6A81EBF05AEQ35146940-5A7023F3-6487-4DA0-95E1-E4AEC0D3DEBEQ35156810-DE02D842-B297-460F-BE50-FDD3CAADD9FFQ35167738-32AE905A-EFE9-46D4-A201-F809073FA2D6Q35200398-E63FF316-BFEA-4B14-8EC3-F6A3E8D9F3E3Q35208186-148655FA-71FE-4944-84EA-F4D835FA1E3AQ35549063-6549B6D0-878F-4676-87F2-311E1B898D34Q35789138-B509D5C6-DEA0-4AB7-979D-310CC12C2084Q35858986-E34A6882-2292-4CDE-B521-3E3E054D5506Q35896484-03A4A1FC-80A3-4DBF-B84A-1E8FFFE16D0DQ35928866-EDE36E82-22F0-49C7-BA2A-315CA1194B94Q36008023-5EA0695B-BB6E-4F56-A5ED-9C0C76D5D760Q36058277-A207235E-3223-44A1-B3AF-96BF5FCAD108Q36235727-C0518C07-0FBB-4EC7-A1FF-29083D095149Q36439271-FD471EA5-18BC-404D-9FFB-25008667FB35Q36467456-2FF6C317-3C48-4267-8194-AF62EBA7EFDAQ36540329-A963F990-BAC8-45BF-AD9D-1A0625510312Q36680250-4AE57C12-8D52-4FD5-ADE9-53B5188BBDDEQ36813186-DE3D7BAE-C518-4FBE-B49D-030B3E5EAD3CQ36993190-6BC54E09-61EA-4A71-804E-A376DAD4BDE7Q37240128-BD7109CE-A5CF-49EE-BC51-101BA1E61773Q37288162-C65AF953-6A79-4D5F-8F02-5F10E25A584BQ37288186-3CDE0C71-BA07-4DF8-92E6-6B519716A973Q37321102-017CA0EA-A6D5-42DD-B2D1-5C3410A74768Q37384166-91D4944F-B1FF-4015-885C-A1640AF56147Q37426055-F1D90664-4A9E-4EFE-8905-811FC26ECF69Q37564967-8E0172E5-45A7-4843-9EF6-58D3F5BE386E
P2860
Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Age and comorbidity as indepen ...... Clinical Trials Group trials.
@en
Age and comorbidity as indepen ...... Clinical Trials Group trials.
@nl
type
label
Age and comorbidity as indepen ...... Clinical Trials Group trials.
@en
Age and comorbidity as indepen ...... Clinical Trials Group trials.
@nl
prefLabel
Age and comorbidity as indepen ...... Clinical Trials Group trials.
@en
Age and comorbidity as indepen ...... Clinical Trials Group trials.
@nl
P2093
P356
P1476
Age and comorbidity as indepen ...... Clinical Trials Group trials.
@en
P2093
Barbara C Graham
Frances A Shepherd
Glenwood D Goss
Johanna N Spaans
Keyue Ding
Lesley Seymour
Marlo Whitehead
Natasha B Leighl
Tim L Winton
Timothy R Asmis
P356
10.1200/JCO.2007.12.8322
P407
P577
2008-01-01T00:00:00Z